Previous Close | 282.48 |
Open | 280.35 |
Bid | 0.00 x 800 |
Ask | 0.00 x 1200 |
Day's Range | 280.52 - 284.00 |
52 Week Range | 188.84 - 284.00 |
Volume | |
Avg. Volume | 1,397,108 |
Market Cap | 107.149B |
Beta (5Y Monthly) | 0.95 |
PE Ratio (TTM) | 45.89 |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | 3.00 (1.06%) |
Ex-Dividend Date | Dec 29, 2022 |
1y Target Est | N/A |
Kalamazoo, Michigan , Jan. 31, 2023 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the fourth quarter and full year of 2022: Fourth Quarter Results Reported net sales increased 10.7% to $5.2 billionOrganic net sales increased 13.2%Reported operating income margin of 15.6%Adjusted operating income margin(1) contracted 70 bps to 26.6%Reported EPS decreased 15.0% to $1.47Adjusted EPS(1) increased 10.7% to $3.00 Fourth Quarter Net Sales Growth Overview Reported Foreign Currenc
Kalamazoo, Michigan, Dec. 28, 2022 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will host a conference call on Tuesday, January 31, 2023 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ending December 31, 2022 and provide an operational update. Final operating results for the quarter will be released at 4:05 p.m. that day. To register for this conference call, please use the following link: Stryker’s Q4 and Full Year 2022 Earnings Call. After re
KALAMAZOO, Mich., December 13, 2022--Stryker (NYSE:SYK) today announced the launch of Citrefix™, a suture anchor system for foot and ankle surgical procedures. The new system uses Citregen™, an award-winning bioresorbable material designed to mimic the chemistry and structure of native bone.1